Celebrex to stay the market, for now
628203
The FDA says that although its decision is to not ban the drug, that possibilty is not ruled out. NEW YORK (CNN/Money) - The US Food and Drug Administration decided Friday not to recall Celebrex but it has not ruled out the possibility.
363593
Oil prices held steady above &#36;46 and most Asian stock markets edged higher on Monday, but Japanese pharmaceutical shares fell after U.S. drug maker Pfizer reported safety risks for its Celebrex arthritis drug.
526650
The painkiller Celebrex is so effective in treating arthritis that doctors will probably continue to prescribe it, despite a new study that shows that, at high doses, it increases the risk of heart attacks.
108249
Pfizer reaffirmed its commitment today to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis, despite a disclosure last week that the drug had increased
507003
BEIJING, Dec. 23 -- Celebrex, a painkiller prescribed to people with arthritis, is still selling well in Shanghai even though US experts recently found an increased risk of heart attacks and strokes for patients taking high dosages of the drug.
360905
Pfizer Chief Executive Hank McKinnell said on Sunday doctors should be made aware of the health risks in prescribing Celebrex to their patients, but the company does not plan to recall its popular arthritis drug.
41856
Pfizer Inc.âs disclosure of a study linking Celebrex to heart attacks, such as Merck &amp; Co.âs withdrawn Vioxx, means demand for the drugs once known as âsuper aspirin
6885
Despite indications that yet another painkiller can lead to heart attacks and strokes, some Utah doctors say the drug should remain on the market until the government completes further investigations.
535922
Prudential Equity Group maintained a &quot;neutral weight&quot; rating on Pfizer (nyse: PFE - news - people ) after Canadian news reports surfaced linking its arthritis drug Celebrex with cardiovascular side effects.
130636
The furor over the safety of arthritis painkilling medications shows no sign of abating. Vioxx is gone from the market, following data linking it to increased cardiovascular risk.
701121
Pfizer (PFE:NYSE - news - research) was treading water Monday morning, hovering around its 52-week low amid reports that it plans to halt advertising of its embattled painkiller Celebrex.
261035
Pfizer Inc. shares rebounded on Tuesday as a study of Alzheimer&#39;s patients found that its arthritis drug Celebrex carried no increased cardiovascular risks, differing from
161619
The fight over the lucrative market for rheumatoid arthritis drugs is heating up. In the last five years, three similar drugs have been introduced that offer patients the promise of getting back on their feet. Now the manufacturers of all three are jockeying for market share so they can be the leader when Medicare's full prescription drug benefit takes effect ...
522912
Children as young as 2 who suffer from arthritis can be treated with Celebrex , but to ensure the painkiller doesn't put them at later risk for heart attacks, their health should be tracked for decades, a Food and Drug Administration advisory panel said yesterday.
301330
New prescriptions for Pfizer Inc.&#39;s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, according to Verispan, a market research company
277613
[India News]: New York, Dec 20 : America&#39;s multibillion dollar pharmaceutical industry has been shaken by reports that Pfizer&#39;s high-profile arthritis drug, Celebrex, is said to cause an increased risk of heart attack.
16752
Drug giant Pfizer is to stop advertising its best-selling arthritis pain reliever Celebrex after a study showed high doses of it were associated with an increased heart attack risk.